AZ8-20791-04095
4 vaccinations
3 coded responses
29 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 170 / PA
- Registered
- 2021-04-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-30
Dose 1 — Pfizer-BioNTech
-
2021-04-20
Dose 2 — Pfizer-BioNTech
-
2021-04-22
Registered in v-safe
- 2021-04-22
-
2021-04-23
Survey response — days 1–6 daily, dose 2MedDRA: Breast feeding, Heavy menstrual bleeding, Menstruation irregular — Feeling: GoodFree text: These were not symptoms today, but were after my first dose. I started menstruating that day, but my bleeding abruptly became lighter and lingered for 2 weeks. This may not be related to the vaccine, as I am breastfeeding any my cycle only returned in May, but still wanted to note it. Also, after my first dose, my breastfeeding infant developed loose stools that lasted about 2 weeks. Again, it may not be related, but still wanted to note it.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-04-27
- 2021-05-04
- 2021-05-11
- 2021-05-18
- 2021-05-27
- 2021-06-01
- 2021-07-20
- 2021-10-19
-
2021-12-02
Dose 3 — Pfizer-BioNTech
- 2022-04-20
- 2022-06-02
-
2022-10-13
Dose 4 — Pfizer-BioNTech
-
2022-10-13
Survey response — day 0, dose 4MedDRA: Pregnancy — Feeling: GoodFree text: Unrelated to vaccine: pregnancyMedDRA releases: 2024-11 · check-in free text available
- 2022-10-15
- 2022-10-16
- 2022-10-17
- 2022-10-18
- 2022-10-19
- 2022-10-20
- 2022-10-27
- 2022-11-03
- 2022-11-10
- 2022-11-17
- 2022-11-24
- 2023-01-12
-
2023-04-13
Survey response — 6 months, dose 4MedDRA: Premature delivery — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · HospitalizationMedDRA releases: 2024-11
-
2023-04-13
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Get care from a doctor or other healthcare professionalHospitalization · 1 call case(s)
- 2023-04-14
-
2023-04-17
Call successfulCompleted over the phone
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-30 | Pfizer-BioNTech | |
| 2 | 2021-04-20 | Pfizer-BioNTech | |
| 3 | 2021-12-02 | Pfizer-BioNTech | No |
| 4 | 2022-10-13 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
VAERS report filed, before or during a call: 1
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): These were not symptoms today, but were after my first dose. I started menstruating that day, but my bleeding abruptly became lighter and lingered for 2 weeks. This may not be related to the vaccine, as I am breastfeeding any my cycle only returned in May, but still wanted to note it. Also, after my first dose, my breastfeeding infant developed loose stools that lasted about 2 weeks. Again, it may not be related, but still wanted to note it.
Release 12 — day 0, dose 4
Systemic reaction (other): Unrelated to vaccine: pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Premature delivery | · | · | ✓ |
| SRO | Breast feeding | ✓ | ✓ | ✓ |
| SRO | Heavy menstrual bleeding | ✓ | ✓ | ✓ |
| SRO | Menstruation irregular | ✓ | ✓ | ✓ |
| SRO | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release